Issue 9/2022
Content (16 Articles)
Update on Melasma—Part I: Pathogenesis
Ana Cláudia C. Espósito, Daniel P. Cassiano, Carolina N. da Silva, Paula B. Lima, Joana A. F. Dias, Karime Hassun, Ediléia Bagatin, Luciane D. B. Miot, Hélio Amante Miot
Update on Melasma—Part II: Treatment
Daniel P. Cassiano, Ana Cláudia C. Espósito, Carolina N. da Silva, Paula B. Lima, Joana A. F. Dias, Karime Hassun, Luciane D. B. Miot, Hélio A. Miot, Ediléia Bagatin
A Review of Phase 3 Trials of Dupilumab for the Treatment of Atopic Dermatitis in Adults, Adolescents, and Children Aged 6 and Up
Jennifer Cather, Melodie Young, Douglas C. DiRuggiero, Susan Tofte, Linda Williams, Tayler Gonzalez
Prurigo Nodularis: A Review of IL-31RA Blockade and Other Potential Treatments
Anthony Bewley, Bernard Homey, Andrew Pink
Randomized Clinical Trial of Conventional versus Indoor Daylight Photodynamic Therapy for Treatment of Actinic Cheilitis
Mariachiara Arisi, Benedetta Galli, Edoardo Guasco Pisani, Giuseppe La Rosa, Gaetano Licata, Sara Rovaris, Cesare Tomasi, Mariateresa Rossi, Marina Venturini, Luigi Spiazzi, PierGiacomo Calzavara-Pinton
Risankizumab for the Treatment of Moderate to Severe Plaque Psoriasis in the Russian Federation
Liudmila Odnopozova, Anton Edin, Alexey Sukharev, Tianshuang Wu, Kerstin Aydin, Maureen Kelly, Alkes Khotko
Durability of Response to Abrocitinib in Patients with Moderate-to-Severe Atopic Dermatitis After Treatment Discontinuation in a Phase 2b Trial
Melinda J. Gooderham, Giampiero Girolomoni, Julian O. Moore, Jonathan I. Silverberg, Robert Bissonnette, Seth Forman, Elena Peeva, Pinaki Biswas, Hernan Valdez, Gary Chan
Treatment Patterns for Targeted Therapies, Non-Targeted Therapies, and Drug Holidays in Patients with Psoriasis
April Armstrong, Qian Xia, Anand Rojer John, Vardhaman Patel, Lauren Seigel
Efficacy, Safety, and Pharmacoeconomic Analysis of Adalimumab and Secukinumab for Moderate-to-Severe Plaque Psoriasis: A Single-Center, Real-World Study
Gaojie Li, Yuanxia Gu, Qin Zou, Yiyi Wang, Yue Xiao, Dengmei Xia, Tongying Zhan, Xingli Zhou, Qian Wang, Wei Yan, Wei Li
High Tolerability, Favorable Safety, and Subjects' Preference for a Single 200 mg/2 mL Tildrakizumab Injection: A Phase I, Open-Label, Randomized Crossover Trial in Healthy Volunteers
Georgios Kokolakis, German Kreis, Meritxell Falqués, Mònica Aparici, Wiebke Sondermann
Dupilumab Treatment of Atopic Dermatitis in Routine Clinical Care: Baseline Characteristics of Patients in the PROLEAD Prospective, Observational Study
Diamant Thaçi, Andrea Bauer, Ralph von Kiedrowski, Florian Schenck, Konstantin Ertner, Sophie Möller, Anja Fait, Mike Bastian, Matthias Augustin
Pretreatment with an Aerosol Foam Containing Calcipotriene and Betamethasone Strongly Improves the Efficacy of Narrow-Band UVB Phototherapy
Gaetano Licata, Mariachiara Arisi, Marina Venturini, Mariateresa Rossi, Cesare Tomasi, Irene Calzavara-Pinton, Piergiacomo Calzavara-Pinton
Reassurance Techniques Do Not Significantly Impact Confidence in Biosimilars for Psoriasis: A Survey of a Convenience Sample of Individuals with Self-Identified Psoriasis
Matthew L. Hrin, Jeremy K. Bray, Steven R. Feldman
Trifarotene 0.005% Cream in the Treatment of Facial and Truncal Acne Vulgaris in Patients with Skin of Color: a Case Series
James Q. Del Rosso, Edward Lain, Jean Philippe York, Andrew Alexis